Clinical Trials Browser

Phase 2 × Oxaliplatin × Breast × Clear all

NCT05007106 2025-08-14

KEYVIBE-005

Phase 2 Completed

BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

NCT01387295 2023-12-11

Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic Disease

Phase 2 Completed

38 enrolled 11 charts

Breast Neoplasms

NCT00297596 2021-10-28

Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer

Phase 2 Completed

25 enrolled 6 charts

Breast Neoplasms, Neoplasm Metastasis

NCT01387373 2020-10-05

Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast Cancer

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT00204776 2019-12-12

XELOX for Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00216021 2015-12-09

Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT01658033 2015-09-09

Bevacizumab Plus Modified FOLFOX6 Regimen as the Salvage Treatment in Metastatic Breast Cancer (MBC) Patients

Phase 2 Completed

Breast Neoplasms

NCT00159458 2014-05-22

Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer

Phase 2 Terminated

Breast Neoplasms

NCT00674206 2013-12-12

A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast Cancer

Phase 2 Terminated

6 enrolled 6 charts

Breast Neoplasms

NCT00527930 2013-10-10

TORCH

Phase 2 Completed

Breast Neoplasms

NCT00006121 2012-07-24

Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy

Phase 2 Terminated

Breast Neoplasms

NCT01528826 2012-02-08

NVBOX

Phase 2 Unknown

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01351597 2011-05-11

STORM

Phase 2 Unknown

Breast Neoplasms

NCT00216073 2011-05-02

Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer

Phase 2 Terminated

Breast Neoplasms

NCT00403988 2008-11-04

Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast Carcinoma

Phase 2 Terminated

Breast Neoplasms